MedPath

SANDOZ BISOPROLOL TABLETS

SANDOZ BISOPROLOL TABLETS

Approved
DIN Number

02494043

Drug Class

Human

Market Date

Nov 27, 2019

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02494043
AIG Number0122418002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C07AB07 BISOPROLOL
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:24.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

BISOPROLOL FUMARATEActive
Strength: 10 MG
Monograph: BISOPROLOL FUMARATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.